Search results
FDA approves Imdelltra for patients with extensive-stage small cell lung cancer
United Press International via Yahoo News· 3 hours agoFood and Drug Administration on Thursday approved a new drug to treat patients with an advanced form...
Amgen shares hold as FDA approves Imdelltra ahead of schedule By Investing.com
Investing.com· 52 minutes agoThe optimism follows the U.S. Food and Drug Administration's (FDA) accelerated approval of Imdelltra...
FDA-Approved HPV Self-Screening Tests Aim to Improve Cervical Cancer Prevention
Verywell Health via Yahoo News· 3 hours agoLalocracio / Getty Images Fact checked by Nick Blackmer Key Takeaways The FDA has approved a new...
FDA approves first self-test for cervical cancer
Homenewshere.com· 10 hours agoThe FDA now says self-collected vaginal samples can now be screened at doctor’s office or urgent care facilities.
FDA approves Amgen drug for tough-to-treat form of lung cancer
BioPharma Dive via Yahoo Finance· 8 hours agoImdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following...
The Best Face Sunscreens Recommended by Star-Loved Skin-Care Experts
The Hollywood Reporter via Yahoo News· 1 hour agoCiting a recent New York Times article on the U.S.’ outdated sunscreen rules, Wechsler says, “If a...
FDA approves self-collection screening tests for HPV, allowing women to avoid pelvic exams for...
FierceBiotech· 2 days agoThe FDA has approved two diagnostic devices that allow women to collect vaginal samples themselves...
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE...
FOX 5 San Diego· 21 hours agoAmgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult ...
Compatibility issues found with autoinjectors, FDA says
Becker’s Hospital Review· 13 hours agoThe FDA is warning healthcare professionals about compatibility issues between autoinjectors and glatiramer acetate injections, which are approved to treat ...
FDA Approves Tarlatamab for Extensive-Stage SCLC
Medscape· 2 days agoContinued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit.